Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the cold war era

American Journal of Industrial Medicine

Volumn 54, Issue 3, 2011, Pages 194-204

  Mikulski, Marek A ^a   Leonard, Stephanie A ^a   Sanderson, Wayne T ^c   Hartley, Patrick G ^b   Sprince, Nancy L ^a   Fuortes, Laurence J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Beryllium; Beryllium exposure assessment; Beryllium sensitization; Former worker program; Medical screenings

Indexed keywords

BERYLLIUM; COPPER; HEAVY METAL;

AGED; ARTICLE; ATOMIC BOMB; ATOMIC WARFARE; BERYLLIOSIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HEALTH SURVEY; HUMAN; INTOXICATION; MALE; MASS SCREENING; OCCUPATIONAL EXPOSURE; RISK; RISK ASSESSMENT; UNITED STATES;

AGED; BERYLLIOSIS; BERYLLIUM; COHORT STUDIES; CONFIDENCE INTERVALS; COPPER; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; METALS, HEAVY; NUCLEAR WARFARE; NUCLEAR WEAPONS; OCCUPATIONAL EXPOSURE; ODDS RATIO; POISONING; RISK ASSESSMENT; UNITED STATES;

EID: 79551624686     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20913     Document Type: Article

References (51)

1. American Thoracic Society (ATS). 1995. Standardization of spirometry. Am J Respir Crit Care Med 152:1107-1136.
2. Agency for Toxic Substances, Disease Registry (ATSDR). 2006. Report: The ATSDR expert panel on BeLPT interpretation to address questions that had been raised about the ATSDR's plan for testing for beryllium sensitization in Elmore, OH. Atlanta, GA: US Department of Health and Human Services. Public. Health Service.
3. Cummings KJ, Deubner DC, Day GA, Henneberger PK, Kitt MM, Kent M, Kreiss K, Schuler CR. 2007. Enhanced preventive program at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med 64:134-140.
4. Dement JM, Welch LS, Bingham E, Cameron B, Rice C, Quinn P, Ringen K. 2003. Surveillance of respiratory diseases among construction and trade workers at Department of Energy nuclear sites. Am J Ind Med 43:559-573.
5. Deubner DC, Goodman M, Iannuzzi J. 2001. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): Preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg 16:521-526.
6. Eisen EA, Robins JM, Greaves IA, Wegman DH. 1984. Selection effects of repeatability criteria applied to lung spirometry. Am J Epidemiol 120:734-742.
7. Freiman DG, Hardy HL. 1970. Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. Beryllium Case Registry. Hum Pathol 1:25-44.
8. Hardy HL, Tabershaw IR. 1946. Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds. J Ind Hyg Toxicol 28:197-211.
9. Hoover MD, Finch GL, Mewhinney JA. 1990. Release of aerosols during sawing and milling of beryllium metal and beryllium alloys. Appl Occup Environ Hyg 5:787-791.
10. Hosmer D, Lemeshow S. 2000. Applied logistic regression. 2nd edition. Hoboken, NJ: Wiley & Sons. p 339-347.
11. Kalra R, Singh SP, Savage SM, Finch GL, Sopori ML. 2000. Effects of cigarette smoke on immune response: Chronic exposure to cigarette smoke impairs antigen-mediated signaling in T-cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther 293:166-171.
12. Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber DA, Young DA, Newman LS. 2001. Beryllium particulate exposure and disease relations in beryllium machining plant. J Occup Environ Med 43:238-249.
13. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. 1983. Changes in the normal maximal expiratory flow volume curve with growth and aging. Am Rev Respir Dis 127:725-734.
14. Kolanz ME. 2001. Introduction to beryllium: Uses, regulatory history, and disease. Appl Occup Environ Hyg 16:559-567.
15. Kreiss K, Newman LS, Mroz MM, Campbell PA. 1989. Screening blood test identifies subclinical beryllium disease. J Occup Med 31:603-608.
16. Kreiss K, Mroz MM, Zhen B, Martyny JW, Newman LS. 1993a. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 148:985-991.
17. Kreiss K, Wasserman S, Mroz MM, Newman LS. 1993b. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med 35:267-274.
18. Kreiss K, Mroz MM, Newman LS, Martyny J, Zhen B. 1996. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am J Ind Med 30:16-25.
19. Madl AK, Unice K, Brown JL, Kolanz ME, Kent MS. 2007. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant. J Occup Envir Hyg 4:448-466.
20. Maier LA. 2002. Genetic and exposure risks for chronic beryllium disease. Clin Chest Med 23:827-839.
21. Maier LA, Martyny JW, Liang J, Rossman MD. 2008. Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med 177:1012-1017.
22. Makie T, Adcock D, Lackland DT, Hoel DG. 2005. Pulmonary abnormalities associated with occupational exposures at the Savannah River site. Am J Ind Med 48:365-372.
23. Middleton DC, Fink J, Kowalski PJ, Lewin MD, Sinks T. 2008. Optimizing BeLPT criteria for beryllium sensitization. Am J Ind Med 51:166-172.
24. National Research Council of the National Academies. 2008. Managing health effects of beryllium exposure. Washington, DC: National Academies Press. p 168.
25. Newman LS. 2000. Immunologic mechanisms in granulomatous lung disease. Immunopharmacology 48:329-331.
26. Newman LS, Kreiss K, King TE, Seay S, Campbell PA. 1989. Pathologic and immunologic alterations in early stages of beryllium disease. Am Rev Respir Dis 139:1479-1486.
27. Newman LS, Mroz MM, Balkissoon R, Maier LA. 2005. Beryllium sensitization progresses to chronic beryllium disease. A longitudinal study of disease risk. Am J Resp Crit Care Med 171:54-60.
28. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Van der Grinten CP, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. 2005. Interpretative strategies for lung function tests. Eur Respir J 26:948-968.
29. Richeldi L, Sorrentino R, Saltini C. 1993. HLA-DPB1 glutamate 69: A genetic marker of beryllium disease. Science 262:242-244.
30. Rodrigues EG, McClean MD, Weinberg J, Pepper LD. 2008. Beryllium sensitization and lung function among former workers at the Nevada Test Site. Am J Ind Med 51:512-523.
31. Rosenman K, Hertzberg V, Rice C, Reilly MJ, Aronchick J, Parker JE, Regovich J, Rossman M. 2005. Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect 113:1366-1372.
32. Sackett HM, Maier LA, Silveira LJ, Mroz MM, Ogden LG, Murphy JR, Newman LS. 2004. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med 46:953-961.
33. Saltini C, Winestock K, kirby M, Pinkston P, Crystal RG. 1989. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 320:1103-1109.
34. Sanderson WT, Ward EM, Steenland K, Petersen MR. 2001a. Lung cancer case-control study of beryllium workers. Am J Ind Med 39:133-144.
35. Sanderson WT, Petersen MR, Ward EM. 2001b. Estimating historical exposures of workers in a beryllium manufacturing plant. Am J Ind Med 39:145-157.
36. Sanderson WT, Leonard S, Ott D, Fuortes LJ, Field RW. 2008. Beryllium surface levels in a military ammunition plant. J Occup Environ Hyg 5:475-481.
37. SAS Institute, Inc. 2002. SAS Institute, Inc. Cary, NC, USA: 2002-2008. SAS 9.1.3.
38. Schuler CR, Kent MS, Deubner DC, Berakis MT, McCawley M, Henneberger PK, Rossman MD, Kreiss K. 2005. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med 47:195-205.
39. Silveira L, Bausch M, Mroz M, Maier L, Newman L. 2003. Beryllium sensitization in the 'general population'. Sarcoidosis Vasc Diffuse Lung Dis 20:157.
40. Stange AW, Furman FJ, Hilmas DE. 1996a. Rocky flats beryllium health surveillance. Environ Health Perspect 104S:981-986.
41. Stange AW, Hilmas DE, Furman FJ. 1996b. Possible health risks from low level exposure to beryllium. Toxicology 111:213-224.
42. Stange AW, Hilmas DE, Furman FJ, Gatliffe TR. 2001. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility. Appl Occup Environ Hyg 16:405-417.
43. Stange AW, Furman FJ, Hilmas DE. 2004. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance. Am J Ind Med 46:207-218.
44. Stanton ML, Henneberger PK, Kent MS, Deubner DC, Kreiss K, Schuler CR. 2006. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers. J Occup Environ Med 48:204-211.
45. Stonehouse JA, Zenczak S. 1991. Properties, production, processes and application. In: Rossman MD, Preuss OP, Powers MB, editors. Beryllium biomedical and environmental aspects. Baltimore: Williams and Wilkins. p 27-55.
46. Taiwo OA, Slade MD, Cantley LF, Fiellin MG, Wesdock JC, Bayer FJ, Cullen MR. 2008. Beryllium sensitization in aluminum smelter workers. J Occup Environ Med 50:157-162.
47. Townsend MC. 2005. Evaluating pulmonary function change over time in the occupational setting. J Occup Environ Med 47:1307-1316.
48. United States Department of Energy (US DOE). 2001. DOE-SPEC-1142-2001. Beryllium lymphocyte proliferation test specification (BELPT). Washington, DC: US Department of Energy.
49. United States Department of Energy (US DOE). 2009. Former worker medical screening program annual report. Washington, DC: US Department of Energy.
50. United States Department of Labor (US DOL). 2005. Medical requirements under the Energy Employees Occupational Illness Program Act (EEOICPA). Washington, DC: United States Department of Labor.
51. Welch L, Ringen K, Bingham E, Dement J, Takaro T, McGowan W, Chen A, Quinn P. 2004. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites. Am J Ind Med 46:207-218.